Summary:
- The article discusses a letter written to the editor-in-chief of the Cochrane organization, which is a renowned source of high-quality, independent evidence on healthcare interventions.
- The letter raises concerns about the Cochrane review on the use of ivermectin for COVID-19, which the author believes has significant flaws and biases that undermine the reliability of the review's conclusions.
- The author argues that the Cochrane review failed to adequately consider the available evidence on ivermectin and calls for a more thorough and impartial re-evaluation of the topic.